REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,712,748 | +228.8% | 26,606 | -15.0% | 0.01% | +350.0% |
| Q4 2021 | $825,000 | -68.2% | 31,294 | +21.4% | 0.00% | -75.0% |
| Q3 2021 | $2,594,000 | -38.9% | 25,784 | -14.0% | 0.01% | -42.9% |
| Q2 2021 | $4,244,000 | +114.0% | 29,988 | +50.8% | 0.01% | +100.0% |
| Q1 2021 | $1,983,000 | -15.2% | 19,890 | +5.2% | 0.01% | -12.5% |
| Q4 2020 | $2,338,000 | +10.9% | 18,915 | -12.6% | 0.01% | 0.0% |
| Q3 2020 | $2,109,000 | -18.7% | 21,647 | +30.2% | 0.01% | -27.3% |
| Q2 2020 | $2,594,000 | +24.2% | 16,625 | +14.9% | 0.01% | +10.0% |
| Q1 2020 | $2,089,000 | -29.4% | 14,474 | 0.0% | 0.01% | -9.1% |
| Q4 2019 | $2,959,000 | – | 14,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $76,391,000 | 14.09% |
| Opaleye Management Inc. | 330,000 | $8,702,000 | 1.85% |
| Highlander Partners, L.P. | 27,600 | $728,000 | 0.89% |
| Ikarian Capital, LLC | 200,000 | $5,274,000 | 0.79% |
| Integral Health Asset Management, LLC | 103,000 | $2,716,000 | 0.75% |
| KRS Capital Management, LLC | 32,841 | $866,000 | 0.74% |
| Ghost Tree Capital, LLC | 55,000 | $1,450,000 | 0.52% |
| MADDEN SECURITIES Corp | 39,312 | $1,037,000 | 0.49% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $801,000 | 0.47% |
| Ikarian Capital, LLC | 100,000 | $2,637,000 | 0.39% |